Guang-Xian Zhang, MD, PhD
Professor
Co-Director, Neuroimmunology Laboratories
Contact
900 Walnut Street
Third Floor
Philadelphia, PA 19107
215-955-8935
215-503-5848 fax
Guang-Xian Zhang, MD, PhD
Professor
Co-Director, Neuroimmunology Laboratories
Research & Clinical Interest
- Neural stem cells/gene therapy in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE).
- T cell and cytokine regulation in the pathogenesis and treatment of neurological autoimmune diseases
Education
PhD, Neuroimmunology - Karolinska Institute
Publications
- Retraction Notice to: Neurotrophin 3 Transduction Augments Remyelinating and Immunomodulatory Capacity of Neural Stem Cells (Molecular Therapy (2014) 22(2) (440–450), (S1525001616311650), (10.1038/mt.2013.241))
- Retraction Notice to: Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity (Molecular Therapy (2016) 24(8) (1456–1469), (S1525001616335973), (10.1038/mt.2016.104))
- Correction to: Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity (Immunologic Research, (2013), 56, 1, (189-196), 10.1007/s12026-013-8393-z)
- Corrigendum to “Upregulation of immunomodulatory molecules by matrine treatment in experimental autoimmune Encephalomyelitis.” [Experimental and Molecular Pathology. 2014; 97(3):470–6. doi: 10.1016/j.yexmp.2014.10.004.] (Upregulation of immunomodulatory molecules by matrine treatment in experimental autoimmune encephalomyelitis (2014) 97(3) (470–476), (S0014480014001646), (10.1016/j.yexmp.2014.10.004))
- Corrigendum: Combination therapy with fingolimod and neural stem cells promotes functional myelination in vivo through a non-immunomodulatory mechanism(Front. Cell. Neurosci., (2019), 13, (14), 10.3389/fncel.2019.00014)